Straight Path Wealth Management Has $318,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Straight Path Wealth Management trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 34.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,504 shares of the pharmacy operator’s stock after selling 18,996 shares during the period. Straight Path Wealth Management’s holdings in Walgreens Boots Alliance were worth $318,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. New Covenant Trust Company N.A. bought a new stake in Walgreens Boots Alliance in the first quarter valued at about $35,000. Iron Horse Wealth Management LLC grew its position in Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares during the period. Blue Trust Inc. raised its stake in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares in the last quarter. Continuum Advisory LLC lifted its holdings in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the period. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at $34,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 3.7 %

Shares of NASDAQ:WBA traded down $0.33 during mid-day trading on Friday, reaching $8.48. 22,188,371 shares of the stock were exchanged, compared to its average volume of 19,571,722. The stock’s 50 day simple moving average is $9.19 and its 200-day simple moving average is $11.90. Walgreens Boots Alliance, Inc. has a one year low of $8.22 and a one year high of $27.05. The company has a market cap of $7.33 billion, a P/E ratio of -0.85, a P/E/G ratio of 1.15 and a beta of 0.69. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter last year, the firm earned $0.67 earnings per share. The firm’s revenue for the quarter was up 5.9% compared to the same quarter last year. As a group, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be paid a dividend of $0.25 per share. The ex-dividend date is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 11.79%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on WBA shares. UBS Group raised their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Morgan Stanley cut their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Evercore ISI increased their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Barclays boosted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Finally, TD Cowen lowered their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.